Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

CUSIP: 00439U104

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Security type / class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
17,347,737
Holder snapshot
Total 13F shares
3,706,227
Share change
-110,681
Total reported value
$11,033,102
Reported price per share
$2.98
Number of holders
20
Value change
-$328,360
Number of buys
6
Number of sells
5

Security key

00439U104

Report period

Q3 2025

Institutions

20

Top holders

10

GRCE full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Grace Therapeutics, Inc. SEC filings Grace Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GRCE - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
ADAR1 Capital Management,...
13D/G signal
ADAR1 Capital Management,...
Evidence rows
15
Latest as of
30 Jun 2025
13F 13D/G 3/4/5 Lead comparable stake: 9.9% 13D/G row: ADAR1 Capital Management, LLC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
ADAR1 Capital Management, LLC
13F 13D/G 3/4/5
Company · ADAR1 Capital Management GP, LLC · 10%+ Owner
13F 13D/G 3/4/5
9.9%
from 13D/G
$524,582
176,627 shares
 — 30 Jun 2025
Nantahala Capital Management, LLC
13F
Company
13F
6.8%
$3,499,263
1,178,203 shares
 — 30 Jun 2025
AIGH Capital Management LLC
13F
Company
13F
6.5%
$3,351,636
1,128,497 shares
 — 30 Jun 2025
BANK OF AMERICA CORP /DE/
13F
Company
13F
2.9%
$1,469,253
494,698 shares
 — 30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
2.4%
$1,215,027
409,100 shares
 — 30 Jun 2025
Stonepine Capital Management, LLC
13F
Company
13F
1.7%
$868,725
292,500 shares
 — 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
3,706,227
Rows available
20
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
20
Q3 2025 holders
20
Holder diff
0
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .